Cargando…

Therapeutic strategies for post-transplant recurrence of hepatocellular carcinoma

Despite stringent selection criteria, hepatocellular carcinoma recurrence after liver transplantation (LT) still occurs in up to 20% of cases, mostly within the first 2–3 years. No adjuvant treatments to prevent such an occurrence have been developed so far. However, a balanced use of immunosuppress...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sposito, Carlo, Citterio, Davide, Virdis, Matteo, Battiston, Carlo, Droz Dit Busset, Michele, Flores, Maria, Mazzaferro, Vincenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494935/ https://www.ncbi.nlm.nih.gov/pubmed/36160651 http://dx.doi.org/10.3748/wjg.v28.i34.4929

Ejemplares similares

The Role of Liver Transplantation in the Treatment of Liver Metastases from Neuroendocrine Tumors
por: Citterio, Davide, et al.
Publicado: (2023)

Permanent Pancreatic Duct Occlusion With Neoprene-based Glue Injection After Pancreatoduodenectomy at High Risk of Pancreatic Fistula: A Prospective Clinical Study
por: Mazzaferro, Vincenzo, et al.
Publicado: (2019)

Liver Transplantation for Hepatic Metastases from Colorectal Cancer: Current Knowledge and Open Issues
por: Maspero, Marianna, et al.
Publicado: (2023)

Long‐term outcomes of resection versus transplantation for neuroendocrine liver metastases meeting the Milan criteria
por: Maspero, Marianna, et al.
Publicado: (2022)

Development of a prognostic scoring system for resectable hepatocellular carcinoma
por: Sposito, Carlo, et al.
Publicado: (2016)

Competing risk analysis on outcome after hepatic resection of hepatocellular carcinoma in cirrhotic patients
por: Cucchetti, Alessandro, et al.
Publicado: (2017)

Impact of Surgical Margins on Overall Survival after Gastrectomy for Gastric Cancer: A Validation of Japanese Gastric Cancer Association Guidelines on a Western Series
por: Maspero, Marianna, et al.
Publicado: (2022)

Impact of Indocyanine Green Fluorescence Imaging on Lymphadenectomy Quality During Laparoscopic Distal Gastrectomy for Gastric Cancer (Greeneye): An Adaptative, Phase 2, Clinical Trial
por: Sposito, Carlo, et al.
Publicado: (2023)

COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy
por: Bhoori, Sherrie, et al.
Publicado: (2020)

Indocyanine Green Fluorescence-Guided Surgery for Gastrointestinal Tumors: A Systematic Review
por: Sposito, Carlo, et al.
Publicado: (2022)

The management of post-transplantation recurrence of hepatocellular carcinoma
por: Rajendran, Luckshi, et al.
Publicado: (2022)

Fermentative Liberation of Ellagic Acid from Walnut Press Cake Ellagitannins
por: Brück, Wolfram M., et al.
Publicado: (2022)

Macrophage morphology and distribution are strong predictors of prognosis in resected colorectal liver metastases: results from an external retrospective observational study
por: Costa, Guido, et al.
Publicado: (2023)

Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma Recurrence
por: Kang, Seong Hee, et al.
Publicado: (2018)

Liver Transplantation for Hepatocellular Carcinoma
por: Mazzaferro, Vincenzo, et al.
Publicado: (2008)

Factors predicting survival after post-transplant hepatocellular carcinoma recurrence
por: Toso, Christian, et al.
Publicado: (2012)

Development and validation of an artificial intelligence model for predicting post‐transplant hepatocellular cancer recurrence
por: Lai, Quirino, et al.
Publicado: (2023)

Reduced Rates of Post-Transplant Recurrent Hepatocellular Carcinoma in Non-Alcoholic Steatohepatitis: A Propensity Score Matched Analysis
por: Lamm, Ryan, et al.
Publicado: (2022)

Y(90)-radioembolisation in hepatocellular carcinoma induces immune responses calling for early treatment with multiple checkpoint blockers
por: Rivoltini, Licia, et al.
Publicado: (2023)

Erratum to: Factors predicting survival after post-transplant hepatocellular carcinoma recurrence
por: Toso, Christian, et al.
Publicado: (2013)

Immune microenvironment and therapeutic progress of recurrent hepatocellular carcinoma after liver transplantation
por: Jin, Xin, et al.
Publicado: (2022)

Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma
por: Mazzaferro, Vincenzo, et al.
Publicado: (2018)

Imaging of hepatocellular carcinoma recurrence after liver transplantation
por: Mamone, Giuseppe, et al.
Publicado: (2023)

Thrombosis after liver transplantation for hepatocellular carcinoma
por: Martinelli, Ida, et al.
Publicado: (2017)

HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma
por: Xue, Feng, et al.
Publicado: (2015)

Multidisciplinary approach for post-liver transplant recurrence of hepatocellular carcinoma: A proposed management algorithm
por: Au, Kin Pan, et al.
Publicado: (2018)

Performance of Dual-tracer PET-CT for Staging Post–Liver Transplant Hepatocellular Carcinoma Recurrence
por: Au, Kin-Pan, et al.
Publicado: (2021)

Combined proteomic/transcriptomic signature of recurrence post-liver transplantation for hepatocellular carcinoma beyond Milan
por: Bhat, Mamatha, et al.
Publicado: (2021)

Salvage living donor liver transplantation for post-resection recurrence of combined hepatocellular carcinoma-cholangiocarcinoma
por: Kim, Minjae, et al.
Publicado: (2021)

Role of Allelic Imbalance in Predicting Hepatocellular Carcinoma (HCC) Recurrence Risk After Liver Transplant
por: Pagano, Duilio, et al.
Publicado: (2019)

Transplantation of autologous extracellular vesicles for cancer-specific targeting
por: Villa, Alessandro, et al.
Publicado: (2021)

Survival benefit from liver transplantation for patients with and without hepatocellular carcinoma
por: Goudsmit, Ben F.J., et al.
Publicado: (2023)

Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach
por: Mazzaferro, Vincenzo
Publicado: (2016)

The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation
por: Ravaioli, Matteo, et al.
Publicado: (2017)

Mediastinal mass diagnosed by endobronchial ultrasound as recurrent hepatocellular carcinoma in a post-liver transplantation patient
por: Alraiyes, Abdul Hamid, et al.
Publicado: (2016)

Impact of stem cell marker expression on recurrence of TACE-treated hepatocellular carcinoma post liver transplantation
por: Zeng, Zhen, et al.
Publicado: (2012)

A218 THE RISK OF RECURRENT HEPATOCELLULAR CARDINOMA IN POST-LIVER TRANSPLANT PATIENTS RECEIVING CAPECITABINE TREATMENT
por: Alsager, M, et al.
Publicado: (2022)

pH regulators to target the tumor immune microenvironment in human hepatocellular carcinoma
por: Kuchuk, Olga, et al.
Publicado: (2018)

Late Recurrence of Hepatocellular Carcinoma after Liver Transplantation
por: Chok, Kenneth S. H., et al.
Publicado: (2011)

Sorafenib for Recurrent Hepatocellular Carcinoma after Liver Transplantation
por: Kim, Bo Hyun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6e1k83bj7jgoucesig4retla5p